当前位置: X-MOL 学术JAMA Intern. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Decreasing Medicare Spending on Prescription Drugs.
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2020-04-01 , DOI: 10.1001/jamainternmed.2019.7064
Robert Steinbrook 1
Affiliation  

In this issue of JAMA Internal Medicine, Feldman and colleagues1 report that Medicare spending on insulin for patients with diabetes was an estimated $7.8 billion, which is $4.4 billion more than the Centers for Medicare & Medicaid Services might have spent by using the prices negotiated by the US Department of Veterans Affairs and their formulary restrictions. Even if the $4.4 billion figure overestimates the potential savings, the potential for lower prices would substantially increase many patients’ access to life-saving insulin products.



中文翻译:

减少处方药上的医疗保险支出。

在本期《JAMA内科医学》中,Feldman及其同事1报告称,Medicare在糖尿病患者胰岛素上的支出估计为78亿美元,比Medicare&Medicaid Services中心通过使用美国退伍军人事务部及其配方限制。即使44亿美元的数字高估了潜在的节省,降低价格的潜力也将大大增加许多患者获得挽救生命的胰岛素产品的机会。

更新日期:2020-04-01
down
wechat
bug